SYNJ2 and neoplasm: Although very few studies have investigated the role SYNJ2 plays in regulating breast cancer, one reported that copy number gain, or increased expression of SYNJ2 in a small cohort of breast cancer patients correlated with shorter survival in ER+ tumours [83].